Loading data
LTRNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 11.51 m USD | 16.13 m USD | 11.89 m USD | 8.6 m USD | 7.57 m USD |
| Operating profit | -17.98 m USD | -22.22 m USD | -17.88 m USD | -14.43 m USD | -12.59 m USD |
| Net income (reported basis) | -17.12 m USD | -20.78 m USD | -15.96 m USD | -14.26 m USD | -12.36 m USD |
| Basic earnings per share | -1.57 USD/share | -1.93 USD/share | -1.47 USD/share | -1.31 USD/share | -1.13 USD/share |
| Diluted earnings per share | -1.57 USD/share | -1.93 USD/share | -1.47 USD/share | -1.31 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.